Advertisement

Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

World MS Day: applying disease-modifying drugs to PPMS

Ocrevus was the first disease modifying drugs approved for primary progressive MS, as well as relapsed forms of MS. After an initial hiccup with UK health regulators, Roche lowered the price of its drug and NICE recommended it for use by the NHS. However, more treatments are needed for progressive forms of MS, so what drugs are currently in the pipeline for this indication?

Download our 2018 Technology, Media & Telecoms Predictions worth over $5,000 for free

Close
Close
Close

Go Top